Monthly Archives: July 2014

FDA Workshop: ERT Immune Response

On June 9, 2014, the Food and Drug Administration’s Center for Drug Evaluation and Research, in co-sponsorship with the National Organization for Rare Disorders (NORD), held a one-day public workshop …

Posted in News | Leave a comment

Shire Enters Strategic Licensing and Collaboration Agreement with ArmaGen

July 23, 2014: Shire announced a worldwide licensing and collaboration agreement for AGT-182, an investigational enzyme replacement therapy (ERT) for the potential treatment of both the central nervous system (CNS) …

Posted in News | Leave a comment